Xn. Bo et al., PHARMACOLOGICAL AND HISTOCHEMICAL EVIDENCE FOR P2X RECEPTORS IN HUMANUMBILICAL VESSELS, European journal of pharmacology, 353(1), 1998, pp. 59-65
The presence of P2X purinoceptors in human umbilical vessels were stud
ied with organ bath recording, radioligand binding assays, autoradiogr
aphy, and immunohistochemistry. In isolated umbilical arteries and vei
ns from normal term pregnancy, both ATP and alpha,beta-methylene ATP c
aused concentration-dependent contractions. ATP-induced responses were
blocked by desensitisation with alpha,beta-methylene ATP. However, bo
th the ATP- and alpha,beta-methylene ATP-induced responses were not an
tagonised by suramin. No significant difference in responses was obser
ved in the vessels with or without endothelial cells. Radioligand bind
ing assays using [H-3]alpha,beta-methylene ATP showed the presence of
a population of high-affinity binding sites in both the arteries and v
eins. The K-d values of the binding sites were 2.77 +/- 1.10 nM for th
e arteries, and 3.23 +/- 1.22 nM for the veins. The maximum binding si
te densities were 634 +/- 237 and 947 +/- 308 fmol/mg protein for the
arteries and the veins, respectively. Autoradiographic localisation wi
th [H-3]alpha,beta-methylene ATP demonstrated that the specific bindin
g sites were only distributed over the smooth muscle cells of the vess
els. Immunohistochemical studies with specific polyclonal antibodies a
gainst P2X(1-6) receptors showed that positive immunostaining was also
restricted to smooth muscle cells. Antibodies against P2X(1) receptor
s produced the strongest signals, while antibodies against the other f
ive P2X subtypes produced much weaker signals. The results in the pres
ent study indicate the existence of P2X purinoceptors in the smooth mu
scle of human umbilical vessels. Their physiological functions remain
to be studied. (C) 1998 Elsevier Science B.V. All rights reserved.